YANET FERRO: Open Payments
NPI 1942867007 · CORAL SPRINGS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$819 in 41 payments from 11 companies in 2025. Trend: 2023 $187 · 2024 $0 · 2025 $819
Food & beverage: $819
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $273 |
| Axsome Therapeutics, Inc. | 4 | $105 |
| Corium, LLC | 6 | $72 |
| Supernus Pharmaceuticals, Inc. | 3 | $66 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $53 |
| Indivior Inc. | 2 | $51 |
| Vanda Pharmaceuticals Inc. | 2 | $40 |
| Tris Pharma Inc | 1 | $21 |
Products named: VRAYLAR, Auvelity, Azstarys, Qelbree, REXULTI, CAPLYTA, TRINTELLIX, SUBLOCADE.
Industry payments across FL — which companies pay providers there.
